Sage Prevalon Patlent Positioning (7530)

Sage Prevalon Patlent Positioning (7530)

Marsoni

M251S

$226.19

Get it in 3 business days with 1 day shipping. Friday, May 29

Sage Prevalon Patlent Positioning (7530)The SPS is uniquely engineered to keep your patient in the optimal, upright seated position without the need for constant boosting or repositionin. The multi chamber air cushion redistributes pressure to provide comfort and security while also reducing friction and shear proven risk factors for pressure ulcers. Includes 1 Seated positioning cushion with fastener strips, (5) microclimate management pads. One way glide keeps patient from moving forward

Easy Shipping

Quick Dispatch:

Your Sage Prevalon Patlent Positioning (7530) orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Sage Prevalon Patlent Positioning (7530) ships.

Need Help?
Questions about Sage Prevalon Patlent Positioning (7530), sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Sage Prevalon Patlent Positioning (7530) in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Delivered the wrong size returned the suit then they delivered the pants minus the vest and jacket Not sure went wrong but was definitely not pleased 10 thumbs down 👎🏾 The tux is a very nice tux and color was on point trued it on was very comfortable feels cool enough to we’re in the summer great quality just sent the wrong size I also sent a email never got a response thanks for messing up my plans

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on March 4, 2026